These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38995306)
1. A Case Report of Fibrillary Glomerulonephritis with Mild Albuminuria: A Viewpoint on Proteomics. Guerra-Torres XE Saudi J Kidney Dis Transpl; 2023 Sep; 34(5):458-461. PubMed ID: 38995306 [TBL] [Abstract][Full Text] [Related]
2. DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN. Dasari S; Alexander MP; Vrana JA; Theis JD; Mills JR; Negron V; Sethi S; Dispenzieri A; Highsmith WE; Nasr SH; Kurtin PJ J Am Soc Nephrol; 2018 Jan; 29(1):51-56. PubMed ID: 29097623 [TBL] [Abstract][Full Text] [Related]
3. A case of juvenile-onset fibrillary glomerulonephritis diagnosed by mass spectrometry and immunohistochemistry of DNAJB9. Hattori K; Shimizu R; Tanaka S; Terashima T; Hiramatsu M; Shimomura T; Ito T; Morinaga T; Terasaki M; Shimizu A; Morozumi K; Tamai H CEN Case Rep; 2022 Nov; 11(4):412-416. PubMed ID: 35199316 [TBL] [Abstract][Full Text] [Related]
4. Fibrillary glomerulonephritis or complement 3 glomerulopathy: a rare case of diffuse necrotising crescentic glomerulonephritis with C3-dominant glomerular deposition and positive DNAJB9. Baker LW; Khan M; Cortese C; Aslam N BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33602773 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients. Nasr SH; Dasari S; Lieske JC; Benson LM; Vanderboom PM; Holtz-Heppelmann CJ; Giesen CD; Snyder MR; Erickson SB; Fervenza FC; Leung N; Kurtin PJ; Alexander MP Kidney Int; 2019 May; 95(5):1269-1272. PubMed ID: 31010480 [TBL] [Abstract][Full Text] [Related]
6. Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9). Klomjit N; Alexander MP; Zand L Kidney360; 2020 Sep; 1(9):1002-1013. PubMed ID: 35369552 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases. Said SM; Rocha AB; Royal V; Valeri AM; Larsen CP; Theis JD; Vrana JA; McPhail ED; Bandi L; Safabakhsh S; Barnes C; Cornell LD; Fidler ME; Alexander MP; Leung N; Nasr SH Am J Kidney Dis; 2021 Mar; 77(3):454-458. PubMed ID: 32711071 [TBL] [Abstract][Full Text] [Related]
8. Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series. El Ters M; Bobart SA; Cornell LD; Leung N; Bentall A; Sethi S; Fidler M; Grande J; Hernandez LH; Cosio FG; Zand L; Amer H; Fervenza FC; Nasr SH; Alexander MP Am J Kidney Dis; 2020 Oct; 76(4):500-510. PubMed ID: 32414663 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker. Liang S; Chen D; Liang D; Xu F; Zhang M; Yang F; Zhu X; Li P; Zeng C J Nephrol; 2021 Jun; 34(3):883-892. PubMed ID: 32557205 [TBL] [Abstract][Full Text] [Related]
10. New developments in the diagnosis of fibrillary glomerulonephritis. Nasr SH; Fogo AB Kidney Int; 2019 Sep; 96(3):581-592. PubMed ID: 31227146 [TBL] [Abstract][Full Text] [Related]
11. DNA J homolog subfamily B member 9 and other advances in fibrillary glomerulonephritis. Andeen NK; Avasare RS Curr Opin Nephrol Hypertens; 2021 May; 30(3):294-302. PubMed ID: 33767057 [TBL] [Abstract][Full Text] [Related]
12. DNAJB9 Fibrillary Glomerulonephritis With Membranous-Like Pattern: A Case-Based Literature Review. Sabanis N; Liaveri P; Geladari V; Liapis G; Moustakas G Cureus; 2023 Oct; 15(10):e47862. PubMed ID: 37899889 [TBL] [Abstract][Full Text] [Related]
13. Complete remission of DnaJ homolog subfamily B member 9-positive fibrillary glomerulonephritis following steroid monotherapy in an elderly Japanese woman. Uchida T; Komatsu S; Sakai T; Kojima A; Iwama S; Sugisaki K; Oda T CEN Case Rep; 2021 Aug; 10(3):442-447. PubMed ID: 33656648 [TBL] [Abstract][Full Text] [Related]
14. Acute kidney injury after Pfizer COVID-19 vaccine due to crescentic fibrillary glomerulonephritis. Al-Sawalmeh K; Pandes M; Niño JA; Avila-Casado C Clin Nephrol; 2022 Oct; 98(4):205-208. PubMed ID: 35900077 [TBL] [Abstract][Full Text] [Related]
15. DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis. Nasr SH; Vrana JA; Dasari S; Bridoux F; Fidler ME; Kaaki S; Quellard N; Rinsant A; Goujon JM; Sethi S; Fervenza FC; Cornell LD; Said SM; McPhail ED; Herrera Hernandez LP; Grande JP; Hogan MC; Lieske JC; Leung N; Kurtin PJ; Alexander MP Kidney Int Rep; 2018 Jan; 3(1):56-64. PubMed ID: 29340314 [TBL] [Abstract][Full Text] [Related]
16. IgA-dominant glomerulonephritis with DNAJB9-negative fibrillar polytypic immunoglobulin deposits in the subepithelium. Muto R; Maeda K; Fukui S; Saito S; Kato N; Kosugi T; Shimizu A; Maruyama S CEN Case Rep; 2023 Aug; 12(3):323-328. PubMed ID: 36576710 [TBL] [Abstract][Full Text] [Related]
17. Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis in a young female: a case study. Singh PP; Krishna A; Sharma A; Kumar O Ultrastruct Pathol; 2020 Nov; 44(4-6):501-504. PubMed ID: 32657244 [TBL] [Abstract][Full Text] [Related]
18. DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients. Said SM; Leung N; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera LH; Sethi S; Zhang P; Nasr SH Kidney Int; 2020 Aug; 98(2):498-504. PubMed ID: 32622524 [TBL] [Abstract][Full Text] [Related]